focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
Wondering which LFT test will to the first to be stamped by the DOH ...surescreen again?? Releasing this RNS late to the market is not giving a lot of confidence in the way they communicate... but they were very quick with the exercise of options RNS after the contract RNS...
we all hoped for a RNS on home trails and there it was but didnt do what we hoped for to the SP...looks like sng001 has a significant postive effect on a certain patient set. Hopefully the outcome of this trail will also speed up enrollment of the p3 trial. And we have to awaite the outcome of this trail and that will be a long wait , in th emeantime it will be difficult to put a price tag on SNG...
There is no mention in the header of the Synairgen website on the home trail results: The Home Study arm of SG016 completed its planned enrolment of 120 COVID-19 patients on 19 January 2021. ..weird ...
i am in this stock against all odds.....all signs are dark red but still havent sold...not a ramper/deramper just frustrated on the level of insight Omega gives. All these twitter 'commercials' end up with a director sell never with a concrete update .. they cant even provide an update on TT . Than the stupid pictures of 10 cars parked at Omega , posted as significant news.... the local mcdonalds has 60 cars parked .. disappointed that i havent sold earlier.. looking at the current price many sellers have the same idea ...every day whitout any news feels like we are being played....i will hold on but once my investment turns red I am out...
last time ODX bounced of the 79p hopefully this will hold again.....no news is not really helping
absolute silence by novacyt ...they killed invester confidence with that rns...no explanation to the market what so ever just a 20 line rns which crashed the SP....this shows the board doesnt have a glue on what is going on or what to state...will be very hectic at HQ ...very unfortunate for the holders above 6 ...only way out is a take over at a ridiculous price but they will be to arrogant to accept ...only real insight into the current issues will bring back investors ....otherwise we will see several TR1 RNS with II decreased holdings
market loves RNS.... -5% pfff great idea to top up yesterday at 82p....they really know how to play the market at ODX....
looks like covid stock shareholders are nervous...every board is full of complaints that their investment is being 'destroyed' by lack of news or due to lacvk of action by the director(s). Investing comes with a lot of risks.. Synairgen has a market cap of 300M and so far revenue is minimal. If Covid momentum is fading we will be hit hard without any update from ongoing trials. and updates will take time maybe another 3 months...will be a bumpy ride...
without anynews we will re test the 79p ..hopefully that holds.
not just red but dark red - oil, btc , covid and tech...and for days now....my porto is deflating like a ballon flying trough the living room... need a drink...
an exercise of options or a rns with sales numbers....will not be surprised if it is the first....
when i boughts these shares. DYOR was done bad...roughly 1m revenue and a MC of 53M..pfff. MC should be around 10x revenue with the remark of 400K of revenue from Beckmann (around 5m per year) 80-85p the SP is in line. Hopefully they have some good forward looking statements tomorrow but dont expect revenue to be more than 10m in 21 ..
All covid testing stocks are down and some significantly unfortunately ... Novacyt , Genedrive , Avacta and Omega ...all stocks are waiting on the same ; the real value of these governmental innitiatives on testing....
why did you invest in ODX when you have no faith in CEO ?
what a statement. Colin build this company and the SP has exploded over the last year. Investors have had huge returns and now he is not fit for the job? because some people here are disappointed on the current SP. Without a test to produce and numbers it is impossible to put a price on this company so expect a sp below 1 until there is real news. unfortunately the market is not having a lot of faith in the testing industry look at NCYT ...